Crump, Nicholas T. http://orcid.org/0000-0001-9610-6763
Smith, Alastair L. http://orcid.org/0000-0001-6330-1407
Godfrey, Laura
Dopico-Fernandez, Ana M. http://orcid.org/0009-0007-7314-3319
Denny, Nicholas
Harman, Joe R. http://orcid.org/0000-0003-3668-1859
Hamley, Joseph C.
Jackson, Nicole E. http://orcid.org/0009-0005-2096-6878
Chahrour, Catherine http://orcid.org/0000-0002-8326-5260
Riva, Simone
Rice, Siobhan
Kim, Jaehoon http://orcid.org/0000-0003-4035-0438
Basrur, Venkatesha
Fermin, Damian
Elenitoba-Johnson, Kojo
Roeder, Robert G. http://orcid.org/0000-0003-3865-8572
Allis, C. David http://orcid.org/0000-0001-7589-713X
Roberts, Irene
Roy, Anindita http://orcid.org/0000-0001-8607-5748
Geng, Huimin
Davies, James O. J.
Milne, Thomas A. http://orcid.org/0000-0002-0413-4271
Funding for this research was provided by:
RCUK | MRC | Medical Research Foundation (MC_UU_00029/6)
RCUK | Medical Research Council (MC_UU_00029/6, MC_UU_00029/6)
Article History
Received: 8 December 2022
Accepted: 18 August 2023
First Online: 25 August 2023
Competing interests
: T.A.M. and N.T.C. are paid consultants for and shareholders in Dark Blue Therapeutics Ltd. J.O.J.D. is a founder of and consultant for Nucleome Therapeutics. The remaining authors declare no competing interests.